A Study of PLX51107 in Advanced Malignancies
NCT02683395
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class
Stopped
Business Decision
Conditions
Solid Tumors
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Non-Hodgkin's Lymphoma
Interventions
DRUG:
PLX51107
Sponsor
Plexxikon